Unknown

Dataset Information

0

Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.


ABSTRACT: Murine chronic graft-versus-host-disease (cGvHD) induced by injection of parental lymphocytes into F1 hybrids results in a disease similar to systemic lupus erythematosus. Here, we have used DBA/2 T cell injection into (C57BL/6?×?DBA/2)F1 (BDF1) mice as a model system to test the prophylactic and therapeutic effects of interleukin-2 (IL-2)/anti-IL-2 immune complexes on the course of cGvHD. Our findings demonstrate that pretreatment with Treg inducing JES6/IL-2 complexes render BDF1 mice largely resistant to induction of cGvHD, whereas pretreatment with CD8+ T cell/NK cell inducing S4B6/IL-2 complexes results in a more severe cGvHD. In contrast, treatment with JES6/IL-2 complexes 4?weeks after induction had no beneficial effect on disease symptoms. However, similar treatment with S4B6/IL-2 complexes led to a significant amelioration of the disease. This therapeutic effect seems to be mediated by donor CD8+ T cells. The fact that a much stronger cGvHD is induced in BDF1 mice depleted of donor CD8+ T cells strongly supports this conclusion. The contrasting effects of the two different IL-2 complexes are likely due to different mechanisms.

SUBMITTER: Heiler S 

PROVIDER: S-EPMC5893767 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.

Heiler Stefan S   Lötscher Jonas J   Kreuzaler Matthias M   Rolink Johanna J   Rolink Antonius A  

Frontiers in immunology 20180404


Murine chronic graft-versus-host-disease (cGvHD) induced by injection of parental lymphocytes into F1 hybrids results in a disease similar to systemic lupus erythematosus. Here, we have used DBA/2 T cell injection into (C57BL/6 × DBA/2)F1 (BDF1) mice as a model system to test the prophylactic and therapeutic effects of interleukin-2 (IL-2)/anti-IL-2 immune complexes on the course of cGvHD. Our findings demonstrate that pretreatment with Treg inducing JES6/IL-2 complexes render BDF1 mice largely  ...[more]

Similar Datasets

| S-EPMC5999794 | biostudies-literature
| S-EPMC6362534 | biostudies-literature
2014-06-03 | E-GEOD-46923 | biostudies-arrayexpress
| S-EPMC5052569 | biostudies-literature
| S-EPMC2891082 | biostudies-literature
| S-EPMC6861327 | biostudies-literature
| S-EPMC4989832 | biostudies-literature
| S-EPMC7686966 | biostudies-literature
2014-06-03 | GSE46923 | GEO
| S-EPMC5237426 | biostudies-literature